January 4, 2017 News by Joana Fernandes, PhD Survey Assesses How Health Professionals Treat Other Health Conditions in MS Patients Healthcare providers frequently assess multiple sclerosis (MS) patients for the development of other health conditions, such as depression, anxiety, pain and sleep disturbance, according to results of a survey-study. The study also includes information about how health professionals treat and counsel MS patients diagnosed with these conditions. The study, ā…
December 22, 2016 News by Alexandra Andersson, PhD Cures Act May Speed Approval of Stem Cell Therapies for MS and Other Diseases The 21st Century Cures Act, recently signed into law by President Barack Obama, includes provisions that aim to speed up the process by whichĀ the U.S. Food and Drug Administration (FDA) reviewsĀ stem cell treatments for patients with degenerative diseases, such as multiple sclerosis, rheumatoid arthritis, and Parkinson’s disease. This act also…
October 12, 2016 News by Alexandra Andersson, PhD Potential Therapy, Laquinimod, Shows Promise as Progressive MS Treatment in Mouse Study The experimental therapyĀ laquinimodĀ was seen to prevent the start of harmful immune responses and to disrupt the progression of multiple sclerosis (MS) in a mouse model of the disease. This finding may be especially promising, as the treatment is being developed for people with both relapsing MS and its rarer progressive…
August 30, 2016 Columns by Ed Tobias Doc Leaves MS Patient ‘Horrified’ ā¦ and Me Too! The other day I received a very troubling direct message from someone on another Multiple Sclerosis website: “I was diagnosed with MS in 2004 but, foolishly, dismissed it. Other than bad spacisity [spasticity] and a few little episodes, I was relatively symptom free. That is until…
August 10, 2016 News by admin 5 Multiple Sclerosis Treatment Options There are no specific therapies that can effectively cure patients with multiple sclerosis. However, there are a number of multiple sclerosis treatment options, particularly for the relapsing-remitting form of the disease. 1.Immunomodulation therapies which can control the inflammation of myelin sheaths and help restore the central nervous system.
May 30, 2016 Columns by admin Run to Win the Race Against MS Welcome to this, the very first installment of my new regular column for Multiple Sclerosis News Today. Here, you canĀ join the race to beat this disease. Run to win. First, let me introduce myself. I am, shall we say, mature ā aged 63; having spent my working life doing what…
March 28, 2016 News by Patricia Silva, PhD MS Survey Reviews How Patients Perceive Diet, Exercise and Drug Treatments A survey, summarizing the views of 2,600 multiple sclerosis (MS) patients, showed how people manage their disease in real life ā and the results offer some surprising insights that might provide clues for future treatment development and optimization. Conducted by aĀ Stanford University-trained geneticist, Dr. Yael Wilnai, results from the…
March 1, 2016 News by Patricia Silva, PhD PhRMA Report Looks at Decade of Progress in Treating MS and Other Chronic Diseases AĀ PhRMA report, titled “A Decade of Innovation in Chronic Diseases,” examined advances made in the treatment of several chronic health conditions, including multiple sclerosis (MS), over the past 10 years that have helped patients to avoid disease complications and hospitalizations, and improve their quality of life.
October 27, 2015 News by Patricia Silva, PhD Consortium of Multiple Sclerosis Centers (CMSC) Emphasizes the Role of Physicians in MS Medical Treatment Decisions The Consortium of Multiple Sclerosis Centers (CMSC), an organization for researchers and healthcare professionals committed to multiple sclerosis (MS) care and treatment, has recently issued a position statement claimingĀ that prescribers should have the right to make clinical decisions on the best treatments and medications in each individual MS case.
September 17, 2015 News by Malika Ammam, PhD Ocrelizumab: a Promising New Treatment for Multiple Sclerosis with Minimal Side Effects On September 16, 2015, Swiss pharmaceutical company Roche announced that ocrelizumab, a drug originally designed to treat rheumatoid arthritis that saw its development stopped due to an association with infections, could potentially treat relapsing-remitting multiple sclerosis (RRMS) as well as primary progressive MS (PPMS) with minimal sides effects compared…
June 3, 2015 News by admin Approach to Treating MS May be Transformed Thanks to Newly Discovered Connection Between Immune-Nervous Systems An exciting new discovery has turned the medical world upside down, and could have important implications for the treatment of multiple sclerosis (MS). It turns out that previously undiscovered vessels exist that connect the nervous system and immune system directly. The study, titled “Structural and functional features…
March 4, 2015 News by admin Multiple Sclerosis Could be Treated with a Surprising Medication An already approved medication used for bladder problems might help to treat multiple sclerosis, according to researchers at the State University of New York at Buffalo. Lead author Fraser J. Sim, PhD, Assistant Professor in the Department of Pharmacology and Toxicology in the University at Buffalo…
September 1, 2014 News by Patricia Silva, PhD New Multiple Sclerosis Drug May Repair Nerve Demyelination As researchers continue to develop a clearer understanding of the underlying causes ofĀ multiple sclerosis (MS), it is becoming increasingly apparent that the future of treating the disease is likely to center on neural protection and a reversal of the demyelination process that strips away the critical insulation…